Biotech giant Amgen, Inc. (AMGN) was downgraded by analysts at William Blair on Tuesday, as the company may be in store for a transitional year in 2013.
The analysts downgraded AMGN from “Outperform” to “Market Perform.”
Amgen shares were down slightly during morning trading on Tuesday. The stock is up about +26% over the past year.
The Bottom Line
Shares of Amgen, Inc. (AMGN) have a dividend yield of 2.23% based on Tuesday’s intraday trading price of $84.43 and the company’s annualized dividend payout of $1.88 per share.
Amgen, Inc. (AMGN)is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.
FREE Dividend Stock Newsletter
Get the Dividend.com email newsletter to receive:
- A free copy of our acclaimed report, 5 Rules of Winning Dividend Stock Investing
- Free daily investing tips and picks from Dividend.com CEO Paul Rubillo
- Tons of great market analysis and recommendations